KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abbott Laboratories (ABT) Change in Inventory (2016 - 2025)

Historic Change in Inventory for Abbott Laboratories (ABT) over the last 17 years, with Q3 2025 value amounting to -$213.0 million.

  • Abbott Laboratories' Change in Inventory rose 318.18% to -$213.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$196.0 million, marking a year-over-year decrease of 970000.0%. This contributed to the annual value of $58.0 million for FY2024, which is 7500.0% down from last year.
  • Per Abbott Laboratories' latest filing, its Change in Inventory stood at -$213.0 million for Q3 2025, which was up 318.18% from -$3.0 million recorded in Q2 2025.
  • In the past 5 years, Abbott Laboratories' Change in Inventory ranged from a high of $554.0 million in Q1 2022 and a low of -$295.0 million during Q4 2023
  • For the 5-year period, Abbott Laboratories' Change in Inventory averaged around $115.7 million, with its median value being $103.0 million (2024).
  • Per our database at Business Quant, Abbott Laboratories' Change in Inventory soared by 942000.0% in 2022 and then crashed by 25608.47% in 2023.
  • Quarter analysis of 5 years shows Abbott Laboratories' Change in Inventory stood at -$15.0 million in 2021, then soared by 1360.0% to $189.0 million in 2022, then tumbled by 256.08% to -$295.0 million in 2023, then grew by 20.34% to -$235.0 million in 2024, then rose by 9.36% to -$213.0 million in 2025.
  • Its last three reported values are -$213.0 million in Q3 2025, -$3.0 million for Q2 2025, and $255.0 million during Q1 2025.